Literature DB >> 25096642

Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.

Susana Viegas1, Mário Pádua, Ana Costa Veiga, Elisabete Carolino, Mário Gomes.   

Abstract

Despite the classification as known or suspected human carcinogens, by the International Agency for Research on Cancer, the antineoplastic drugs are extensively used in cancer treatment due to their specificity and efficacy. As human carcinogens, these drugs represent a serious threat to the healthcare workers involved in their preparation and administration. This work aims to contribute to better characterize the occupational exposure of healthcare professionals to antineoplastic drugs, by assessing workplace surfaces contamination of pharmacy and administration units of two Portuguese hospitals. Surface contamination was assessed by the determination of cyclophosphamide, 5-fluorouracil, and paclitaxel. These three drugs were used as surrogate markers for surfaces contamination by cytotoxic drugs. Wipe samples were taken and analyzed by HPLC-DAD. From the total of 327 analyzed samples, in 121 (37 %) was possible to detect and quantify at least one drug. Additionally, 28 samples (8.6 %) indicate contamination by more than one antineoplastic drug, mainly in the administration unit, in both hospitals. Considering the findings in both hospitals, specific measures should be taken, particularly those related with the promotion of good practices and safety procedures and also routine monitoring of surfaces contamination in order to guarantee the appliance of safety measures.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25096642     DOI: 10.1007/s10661-014-3969-1

Source DB:  PubMed          Journal:  Environ Monit Assess        ISSN: 0167-6369            Impact factor:   2.513


  43 in total

Review 1.  Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods.

Authors:  Roberta Turci; Cristina Sottani; Giuseppe Spagnoli; Claudio Minoia
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-06-15       Impact factor: 3.205

2.  Occupational exposure to antineoplastic drugs in seven Italian hospitals: the effect of quality assurance and adherence to guidelines.

Authors:  Roberta Turci; Claudio Minoia; Cristina Sottani; Raffaella Coghi; Paolo Severi; Cecilia Castriotta; Massimo Del Bianco; Marcello Imbriani
Journal:  J Oncol Pharm Pract       Date:  2010-09-07       Impact factor: 1.809

3.  Pilot study comparing the efficacy of two cleaning techniques in reducing environmental contamination with cyclophosphamide.

Authors:  Karine Touzin; Jean-François Bussières; Eric Langlois; Michel Lefebvre; Angélique Métra
Journal:  Ann Occup Hyg       Date:  2010-01-29

4.  Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies.

Authors:  Thomas H Connor; Paul J M Sessink; Bruce R Harrison; Jack R Pretty; Byron G Peters; Raul M Alfaro; Appie Bilos; Gwendolyn Beckmann; Michael R Bing; Lakisha M Anderson; Robert Dechristoforo
Journal:  Am J Health Syst Pharm       Date:  2005-03-01       Impact factor: 2.637

5.  Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden.

Authors:  M Hedmer; A Georgiadi; E Rämme Bremberg; B A G Jönsson; S Eksborg
Journal:  Ann Occup Hyg       Date:  2005-08-26

6.  ISOPP standards of practice. Safe handling of cytotoxics.

Authors: 
Journal:  J Oncol Pharm Pract       Date:  2007       Impact factor: 1.809

7.  Cytogenetic consequences after occupational exposure to antineoplastic drugs.

Authors:  A Fucic; A Jazbec; A Mijic; D Seso-Simic; R Tomek
Journal:  Mutat Res       Date:  1998-08-07       Impact factor: 2.433

8.  An investigation of oxidative DNA damage in pharmacy technicians exposed to antineoplastic drugs in two Chinese hospitals using the urinary 8-OHdG assay.

Authors:  Yu Wen Huang; Le Jian; Mei Bian Zhang; Quan Zhou; Xiao Feng Yan; Xu Dong Hua; Ying Zhou; Ji Liang He
Journal:  Biomed Environ Sci       Date:  2012-02       Impact factor: 3.118

9.  Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals.

Authors:  Chun-Yip Hon; Kay Teschke; Winnie Chu; Paul Demers; Scott Venners
Journal:  J Occup Environ Hyg       Date:  2013       Impact factor: 2.155

10.  Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.

Authors:  M Hedmer; H Tinnerberg; A Axmon; B A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-12-08       Impact factor: 3.015

View more
  5 in total

1.  Field evaluation of onsite near real-time monitors for surface contamination by 5-fluorouracil.

Authors:  Jerome P Smith; Deborah Sammons; Shirley Robertson; Edward Krieg; John Snawder
Journal:  J Oncol Pharm Pract       Date:  2018-06-27       Impact factor: 1.809

Review 2.  A review of high performance liquid chromatographic-mass spectrometric urinary methods for anticancer drug exposure of health care workers.

Authors:  Patricia I Mathias; Thomas H Connor; Clayton B'Hymer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-06-19       Impact factor: 3.205

3.  A simple approach to assess the cancer risk of occupational exposure to genotoxic drugs in healthcare settings.

Authors:  Johannes Gerding; Lea Anhäuser; Udo Eickmann; Albert Nienhaus
Journal:  J Occup Med Toxicol       Date:  2022-04-01       Impact factor: 2.646

Review 4.  Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.

Authors:  Kurinchi Selvan Gurusamy; Lawrence Mj Best; Cynthia Tanguay; Elaine Lennan; Mika Korva; Jean-François Bussières
Journal:  Cochrane Database Syst Rev       Date:  2018-03-27

5.  Environmental Contamination and Occupational Exposure of Algerian Hospital Workers.

Authors:  Eline Verscheure; Matteo Creta; Jeroen Vanoirbeek; Meziane Zakia; Taleb Abdesselam; Robin Lebegge; Katrien Poels; Radu-Corneliu Duca; Lode Godderis
Journal:  Front Public Health       Date:  2020-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.